This inventor holds 2 USPTO granted patents. Top assignees: Alkermes, Inc., University of California. Active years: 1997-1999.
Company Filing History:
2 out of 76 
2 out of 15,964 
Years Active: 1997-1999
Title: Ruth M Starzyk: Innovator in Neuropharmaceutical Delivery
Introduction
Ruth M Starzyk is a prominent inventor based in Framingham, MA (US). She has made significant contributions to the field of neuropharmaceuticals, particularly in the development of methods for delivering therapeutic agents across the blood-brain barrier. With a total of 2 patents, her work has the potential to impact the treatment of various neurological conditions.
Latest Patents
Ruth's latest patents include the "Transferrin receptor specific ligand-neuropharmaceutical agent fusion" and the "Transferrin neuropharmaceutical agent fusion protein." These inventions focus on a method for delivering a neuropharmaceutical agent to the brain by utilizing a ligand that is reactive with brain capillary endothelial cell receptors. The delivery system she developed comprises a fusion protein that enhances the effectiveness of neuropharmaceutical agents.
Career Highlights
Throughout her career, Ruth has worked with notable organizations such as Alkermes, Inc. and the University of California. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ruth has collaborated with esteemed colleagues, including Eun-Chung Park and Sherie L Morrison. These partnerships have further enriched her research and development efforts in neuropharmaceutical delivery systems.
Conclusion
Ruth M Starzyk's innovative work in neuropharmaceutical delivery showcases her dedication to advancing medical science. Her patents and collaborations highlight her significant contributions to the field, paving the way for future advancements in treating neurological disorders.